Marvel Biosciences Corp.
MBCOF
$0.0975
$0.011212.98%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.94% | 35.51% | 44.59% | 29.02% | -13.65% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,083.84% | 595.37% | 416.15% | 249.58% | -64.32% |
| Change in Net Operating Assets | -84.66% | -72.66% | -107.19% | -79.19% | 87.40% |
| Cash from Operations | 12.57% | 20.04% | 2.42% | 12.70% | 5.19% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 85.00% | -100.00% | -50.00% | -50.00% | -50.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 66.67% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -613.64% | 100.00% |
| Cash from Financing | 156.44% | -68.97% | -3.49% | -25.82% | -70.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 119.98% | -288.19% | -2.27% | -361.90% | -322.92% |